Andreas Blum

Andreas Blum

Auto-generated profile, based on publicly available information

Andreas Blum

Hautarzt- und Lehrpraxis Konstanz, Konstanz, Deutschland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ABA. Blum
A. Blum
HLH. Luedtke
H. Luedtke
UEU. Ellwanger
U. Ellwanger
RSR. Schwabe
R. Schwabe
GRG. Rassner
G. Rassner
Claus GarbeClaus Garbe
Claus Garbe

1 October 2011 in Archives of Dermatology
Verified
Journal Article
Open access
PDF file
ABAndreas Blum
Andreas Blum
OSOlga Simionescu
Olga Simionescu
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
RBRalph Braun
Ralph Braun
HCHoracio Cabo
Horacio Cabo
HKHARALD KITTLER
HARALD KITTLER
Dermoscopy is widely used for the diagnosis of pigmented and nonpigmented lesions of the skin, nail apparatus, and hairy and volar skin, but it is yet not well established for pigmented mucosal lesions.1-3 A major reason for this might be that mucosal lesions are rare in the clinical setting and have not been well characterized by dermoscopy. In addition, it is unknown if dermoscopy improves the diagnostic accuracy of pigmented mucosal lesions in comparison with examination with the unaided eye. Only case reports and small case series have been published so far.4-12 The largest studies were by Lin et al,13 which included 40 mucosal lesions, and by Ronger-Savle et al,14 which included 68 lesions on the vulva only. To obtain a larger number of cases, the International Dermoscopy Society (IDS) launched a multicenter retrospective, observational study to better characterize the dermoscopic features of benign and malignant pigmented mucosal lesions.15

1 August 2013 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Open access
PDF file
APAnnette Pflugfelder
Annette Pflugfelder
CKCorinna Kochs
Corinna Kochs
ABAndreas Blum
Andreas Blum
MCMarcus Capellaro
Marcus Capellaro
CCChristina Czeschik
Christina Czeschik
DSDirk Schadendorf
Dirk Schadendorf
This first German evidence-based guideline for cutaneous melanoma was developed under the auspices of the German Dermatological Society (DDG) and the Dermatologic Cooperative Oncology Group (DeCOG) and funded by the German Guideline Program in Oncology. The recommendations are based on a systematic literature search, and on the consensus of 32 medical societies, working groups and patient representatives. This guideline contains recommendations concerning diagnosis, therapy and follow-up of melanoma. The diagnosis of primary melanoma based on clinical features and dermoscopic criteria. It is confirmed by histopathologic examination after complete excision with a small margin. For the staging of melanoma, the AJCC classification of 2009 is used. The definitive excision margins are 0.5 cm for in situ melanomas, 1 cm for melanomas with up to 2 mm tumor thickness and 2 cm for thicker melanomas, they are reached in a secondary excision. From 1 mm tumor thickness, sentinel lymph node biopsy is recommended. For stages II and III, adjuvant therapy with interferon-alpha should be considered after careful analysis of the benefits and possible risks. In the stage of locoregional metastasis surgical treatment with complete lymphadenectomy is the treatment of choice. In the presence of distant metastasis mutational screening should be performed for BRAF mutation, and eventually for CKIT and NRAS mutations. In the presence of mutations in case of inoperable metastases targeted therapies should be applied. Furthermore, in addition to standard chemotherapies, new immunotherapies such as the CTLA-4 antibody ipilimumab are available. Regular follow-up examinations are recommended for a period of 10 years, with an intensified schedule for the first three years.

1 May 2003 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ABAndreas Blum
Andreas Blum
GRGernot Rassner
Gernot Rassner
Claus GarbeClaus Garbe
Claus Garbe

21 September 2004 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
ABA Blum
A Blum
RHR Hofmann‐Wellenhof
R Hofmann‐Wellenhof
HLH Luedtke
H Luedtke
UEU Ellwanger
U Ellwanger
ASA Steins
A Steins
HSH Peter Soyer
H Peter Soyer

1 October 2001 in Archives of Dermatology
Verified
Journal Article
Open access
PDF file
JBJuergen Bauer
Juergen Bauer
GMGisela Metzler
Gisela Metzler
GRGernot Rassner
Gernot Rassner
Claus GarbeClaus Garbe
Claus Garbe
ABAndreas Blum
Andreas Blum
Background Histopathologically, the diagnosis of nevus-associated melanoma or melanoma close to a common nevus can be missed if the specimen is cut in a nonrepresentative area or if the section shows only the associated common nevus. Objective To find out whether dermatoscopy of suspicious areas within a nevus can improve the histological diagnosis of malignant melanocytic lesions of the skin. Materials The study was based on dermatoscopic images of more than 2000 benign and 115 malignant pigmented lesions and a collection of corresponding histopathologic slides. Methods The dermatoscopic images and the corresponding histopathologic diagnoses were compared. In case of differences, the histopathologic findings were reevaluated and compared with the dermatoscopic findings. Results Three cases were identified in which melanoma could have been histopathologically missed as a result of improper sectioning. After the dermatoscopic findings were evaluated, the specimens were reembedded and further sections were obtained. Finally, nevus-associated melanoma or melanoma close to a common nevus was diagnosed. Conclusions Specific dermatoscopic patterns of malignancy can be found in highly suspicious areas, eg, broadened networks, radial streaming, pseudopods, or dots located at the periphery. The dermatoscopic-histopathologic correlation can improve the diagnosis of melanoma. Therefore, the clinician should point to the most suspicious area with a drawing or image, and the suspected diagnosis of melanoma and the history of the lesion should be also mentioned.